Concepedia

B.P. England

BE

9

Publications

1.2K

Citations

9

H-Index

1985

Active since

Affiliations

University of California, Berkeley(Current)

Affymax (United States)

Plexxikon (United States)

Yale University

B.P. England is an author at University of California, Berkeley specializing in medicine, natural sciences, and medicinal chemistry.

Top concepts

MedicineNatural SciencesBiochemistryPharmacologyDrug DiscoveryMedicinal ChemistryGeneticsGene ExpressionGene RegulationMolecular Genetics

Publications per year

1985–2008

9

Publications

9

Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases

G.L. Card, B.P. England, Yoshihisa Suzuki et al. · Structure · 2004 · 425 citations · Full text

Drug Target, Biochemistry, Medicine +6

Characterization of drosophila transcription factors that activate the tandem promoters of the alcohol dehydrogenase gene

Ulrike Heberlein, B.P. England, Robert Tjian · Cell · 1985 · 231 citations

Transcriptional Regulation, Developmental Biology, Genetics +10

A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design

G.L. Card, Landy K. Blasdel, B.P. England et al. · Nature Biotechnology · 2005 · 205 citations · Full text

Medicinal Chemistry, Biochemistry, Drug Design +9

Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent

Dean R. Artis, Jack J. Lin, Chao Zhang et al. · Proceedings of the National Academy of Sciences · 2008 · 146 citations · Full text

Metabolic Syndrome, Medicinal Chemistry, Biochemistry +15

Purified Drosophila transcription factor, Adh distal factor-1 (Adf-1), binds to sites in several Drosophila promoters and activates transcription.

B.P. England, Ulrike Heberlein, Robert Tjian · Journal of Biological Chemistry · 1990 · 63 citations · Full text

Several Drosophila Promoters, Adh Distal Factor-1, Transcriptional Regulation +11

Rows per page

1–5 of 9